|Articles|March 1, 2001
Bristol-Meyers Squibb Co. Stock Drops After Investigation Announcement
Advertisement
NEW YORK-Federal investigators are looking at pharmaceutical giant Bristol-Meyers Squibb Co. after reports that the company gave free drugs and devices to doctors in exchange for purchase of other Bristol drugs.
Bristol stock fell 3% Tuesday after the announcement. A company spokesperson said it was cooperating with the federal investigation and felt its pricing practices complied with the law.
Investigators are also looking at whether the company encouraged doctors to bill Medicare and Medicaid improperly.
Information from www.usatoday.com
Newsletter
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Infection Control Today
1
Bug of the Month: The Quiet Guest in the Dust
2
Manual Cleaning vs Automation: Achieving Consistent Cleanliness for Ultrasound Device Reprocessing
3
Continuous Photohydrolysis Disinfection Cuts MDROs, COVID-19, and Hospital Transfers in Long-Term Care, Study Finds
4
Influenza D and Canine Coronavirus: Why Underrecognized Animal Viruses May Be the Next Respiratory Threat
5